Document Type : Original Research Article


1 Salamat yar behesht dayan ,Dayan biotech company , Tehran, Iran

2 Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Centre for processing and charactrization of nanostructred materials, School of mechanical engineering, University of Tehran, Tehran Iran

4 Internal of Medicine, Faculty Member, Department of Medicine, Zabol University of Medical Sciences, Zabol, Iran

5 Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran

6 Department of Computer Science, Al-Turath University College, Al-Mansour, Baghdad, Iraq

7 Department of Oral and Maxillofacial surgery, School of Dentistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


In this research attempted to prepare hematite (α-Fe2O3) and silver doped hematite nanoparticles (Ag-doped α-Fe2O3 NPs) by using the aqueous extract of Prosopis farcta fruit. The synthesized NPs were identified through the results of X-ray Diffraction (XRD), Field Energy Scanning Electron Microscopy (FESEM), Raman, Energy Dispersive X-ray (EDX), and Vibrating Sample Magnetometer (VSM) technics. Accordingly, the NPs contained a spherical shape with a size range of 40-50 nm. Also, we surveyed their cytotoxic against human breast cancer (MCF-7) cell line, which showed a potential functionality at the concentration of 80 μg/mL. Therefore, the synthesized NPs can be proposed as an applicable candidate for medical applications.


The science of nanotechnology has helped in facilitating the diagnosis and treatment of diseases [1, 2]. Magnetic nanoparticles proved to contain a great ability for improving the diagnosis and cure of various illness, especially cancer [3, 4]. Their application as contrast enhancers in conventional magnetic resonance imaging, as well as nanocarriers in modern drug delivery systems, attracted the interest of many researchers in recent years. Valuable and desirable results were achieved by the performed assessments on the targeted transfer of chemotherapy agents to cancer cells with the help of magnetic nanoparticles throughout in vitro and in vivo conditions [3]. In addition, these particles were exerted for the treatment of cancer through the method of heating, as well as in the transferring of nucleic acids, plasmids, and siRNA to cells [3].
Providing the early-stage diagnosis of diseases is a very important factor in the improvement of treatment methods. Nowadays, the exerted treatments for the diagnosis of cancer are usually based on detecting the induced changes in cells and tissues, which can be also conducted by clinical trials and conventional imaging techniques [5]. However, the goal of scientists is to succeed in identifying cancer upon the occurrence of the first molecular changes [5-8]. Iron oxide nanoparticles are currently the only magnetic nanomaterials that are used as a carrier in drug delivery and a contrast agent in clinical medicine for magnetic resonance imaging [3]. According to the performed experiments on iron oxide nanoparticles over several years, these particles do not cause any immediate or long-term toxic effects on the body and also, their functionality on cells can be enhanced by the presence of certain nanoparticles with nanocarriers [3].
Breast cancer is the important type of cancer in womenfolk [9, 10]. The available common cancer cure involved radiation therapy, surgery, and chemotherapy, that often result in annihilating the healthy cells, while causing the risk of toxic impacts and side effects [10]. In recent years, the lack of radiotherapy and chemotherapy for the progressive forms of cancer, it is necessary to discover new techniques to control cancer, which is one of the applications of NPs, especially iron oxide nanoparticles [11].
In recent years, a lot of attention was invested in the synthesis of nano-sized iron particles due to their extended capabilities as a result of increasing their surface area and surface activity in nanoscale [12-16]. Considering the importance of iron oxide nanoparticles in medical and non-medical fields, researchers attempted the production of these nanoparticles through green synthesizing methods. Iron oxide nanoparticles are widely exerted as catalysts and sensors, as well as for magnetic storage and drug delivery implementations [17].
Biosynthesizing techniques that implicate the usage of plant extracts are simple, efficient, cost-effective, and applicable approaches that can stand as suitable alternatives to conventional preparation methods for increasing the production of nanoparticles [18]. Plants contain biomolecules such as carbohydrates, proteins, and coenzymes that can provide a great potential for reducing metal salts into nanoparticles and maintain their stabilization [18]. Therefore, this study attempted to synthesize pure and Ag-doped α-Fe2O3 NPs through aqueous extract of Prosopis farcta fruit, and in the following examined their cytotoxic activity on breast cancer cell line.
prepare of Prosopis farcta
The fruit of P. farcta was acquired, washed, and dried at room temperature to be powdered and weighed. Then, distilled water was added to the fruit powder in the ratio of 10:1 to be shaken for 10 h. The mixture filtered and resulted extract was exerted for the synthesis of nanoparticles. 

prepare of α-Fe2O3 NPs 
To start the prepare of Fe2O3 NPs, 15 mL of extract was volumed to 50 mL with distilled water. Then, iron (III) chloride (FeCl3, 1M) solution was added to the extract and stirred at 80 ˚C for 4 h. Once the pH of solution was regularized to 11 using sodium hydroxide (NaOH, 1 M, Merck) solution, the resulting mixture dried at 90 °C. The resulted powder calcined at 500 ˚C for 1:30 h to achieve the powder nanoparticles of iron oxide.

prepare of Ag-doped α-Fe2O3 NPs 
For the synthesis of Ag-doped α-Fe2O3, 15 mL of the extract taken at 70 ˚C of water bath to be afterwards volumed to 50 mL by distilled water. Then, FeCl3 (0.1 M, Merck) was adjoined to extract solution. After a few minutes, silver nitrate (Ag(NO3), 0.025 M, Merck) was added and mixed with the reaction container for 2 h at 75 ˚C. Once the pH of solution was compatible by usage of sodium hydroxide (NaOH, 1M, Merck, pH=11), obtained solution placed in oven at 90 ˚C for 12 h. Subsequent to being dried, the resulted precipitate was calcinated at 500 ˚C for 1:30 h to achieve brown powder of Ag-dop-α-Fe2O3 NPs.

Cytotoxic test
Breast (MCF-7) cancer cells purchased from the Pasteur Institute (Tehran, Iran) for toxicity assessment of α-Fe2O3 and Ag-doped α-Fe2O3 nanoparticles. The cells cultured in DMEM (4.5 g/L) with 10% (v/v) FBS, 100 mg/mL of streptomycin, and 100 units/mL of penicillin within a CO2 (5% CO2, 37 °C) incubator. The cells were taken into culture plates until to reaching 80% of growth. On the next day, diverse concentrations of NPs (5-320 µg/mL) were separately added and then, the cells were incubated at 37 °C for 24 h. After the incubation completed, MTT solution in PBS (5 mg/mL) added to each well and another incubation process was performed for 3 h at 37 °C. The absorbance (Abs) of dissolved formazan was evaluated at 570 nm using plate reader (Stat FAX303). The outcomes reported as mean ± SD. The viability of cured cells estimated by the below equation.  

Viability (%) = (Abs of treated cells /Abs of control)* 100

The x-ray diffraction of α-Fe2O3 and Ag-doped α-Fe2O3 NPs are showed in Fig. 1. The diffraction pattern of α-Fe2O3 exhibited peaks in the 2θ positions of 25.21, 34.12, 35.58, 41.18, 49.51, 53.71, 58.86, and 61.28˚ that were related to the (021), (104), (110), (113), (024), (116), (018), and (214) planes. These Miller indices indicated the presence of hematite nanoparticles (α-Fe2O3) (JCPDS card no. 39-1346) [4]. According to Fig. 1, the diffraction pattern of Ag-doped α-Fe2O3 NPs displayed some additional peaks in the 2θ position of 38.1, 43.2, 65.4, and 72.1˚, which implied the presence of silver atom throughout the crystalline structure of doped NPs. Based on the detected diffraction peak at 2θ˚=35.58˚, the crystalline particle size of α-Fe2O3 was calculated by the usage of Debye-Scherer’s equation be 34.50 and 41.59 nm for α-Fe2O3 and Ag-doped α-Fe2O3 NPs, respectively. According to the comparison between the ion radius of silver (1.26 Å) and Fe (0.645 Å), the crystalline size of doped nanoparticles was larger than the pure nanoparticles. 

The particle size and morphology of synthesized pure and Ag-dop-α-Fe2O3 NPs observed through the SEM images (Fig. 2). Accordingly, pure and doped nanoparticles contained a spherical shape and the particle sizes of 40 and 50 nm for pure and Ag-dop-α-Fe2O3 NPs, respectively. In conformity to Fig. 2, the doping of silver into the hematite structure resulted in reducing the particle size, which was also indicated by PXRD findings. The EDX outcomes are presented in Fig. 3, which clearly certifies the presence of doped silver in the nanoparticles.

The Raman of synthesized pure and Ag-dop-α-Fe2O3 NPs exhibited at Fig. 4. Raman spectrum of α-Fe2O3 NPs displayed bands at 296, 414, and 667 cm-1. The bands at 296 and 414 cm -1 are in correspondence to phonon A1g and Eg modes. Peak at 667 cm-1 depended to the attendance of iron oxide NPs. The Raman diagram of Ag-dop-α-Fe2O3 NPs displayed the appearance of a peak at 598 cm-1, which was attributed to A1g mode and signified the α-Fe2O3 sample. According to previous study [12], the Raman spectrum exhibited two modes for the α-Fe2O3 nanoparticles including A1g (595 cm-1) and Eg (422 cm-1), while the observed shift throughout the graph was pertinence to the presence of silver in the sample’s structure. 

The magnetic effect of the synthesized pure and Ag-dop-α-Fe2O3 NPs investigated through results of VSM technique (Fig. 5). As it is displayed in Fig. 5, the magnetic saturation (Ms) of α-Fe2O3 NPs was 1.5 emu/g. According to similar work, α-Fe2O3 contained a magnetic saturation (Ms) value of 1.8 emu/g [12]. The small hysteresis loop of α-Fe2O3 NPs is indicative of its superparamagnetic behavior. Since paramagnetic substances are a type of soft magnetic, their easy magnetization, they rapidly miss their magnetic moments upon the removal of applied magnetic field [19]. According to the survey of Bepari et al on the magnetic effect of Fe2O3 NPs, the Ms content of these NPs has a straight linkage to their particle size and shape anisotropy [20]. The saturation magnetization of Ag-dop-α-Fe2O3 NPs was determined to be 0.16 emu/g (Fig. 5). Apparently, the presence of silver in the structure of nanoparticles caused a decrease in the saturation magnetization of samples.

Cytotoxic performance
We studied the cytotoxic activity of pure and Ag-dop-α-Fe2O3 NPs on MCF-7 using a MTT test. MTT, as a determinant of cytotoxicity and cell viability, was estimated to assign the rate of cellular metabolic performance in cured mitochondria cells. This test was functioned with the NPs concentrations of 0-200 µg/mL in 24 h of treatment time (Fig. 6). Based on Fig. 6, the cytotoxic of synthesized pure and Ag-dop-α-Fe2O3 NPs on the cancer cell of MCF-7 were observed at the concentrations of 320 and 80 µg/mL. Accordingly, the Ag-dop-α-Fe2O3 NPs were able to annihilate 50% of the cells and performed a complete annihilation at concentrations above 80 µg/mL. Fig. 6 depicts the conditions of normal and cancer cells before and after being treated with the synthesized nanoparticles in different concentrations. The toxicity effects of synthesized nanoparticles can be clearly perceived, which resulted in the destruction and death of cells.
The potential cytotoxicity of nanoparticles is caused by their ROS or Reactive oxygen species [21]. Therefore, oxidative stress can be an applicable scale for comparing the toxic effects of nanoparticles [22]. According to most of the related studies, iron oxide nanoparticles at the concentration range of 100 µg/mL and above can cause toxic effects on different cell lines [23], which is consistent with the outcomes of this work. Metal nanoparticles can produce toxins in human tissues and cell cultures, which increases the rate of oxidative stress and inflammatory products such as cytokines, and ultimately leads to the inducement of cell death [24].  Here, the degree of toxicity was observed to be increased as a result of enlarging the applied concentration, which is consistent with the findings of other assessments. Nevertheless, the conduction of in-depth studies is required to obtain a better comprehension on the real mechanism behind the cytotoxic activity of synthesized nanoparticles.

This paper introduces an inexpensive, efficient, and fast synthetic path for producing the pure and Ag-dop-α-Fe2O3 NPs by extract of Prosopis farcta fruit. The traits of synthesized NPs determined by many methods such as XRD, Raman, and FESEM. According to the obtained results, the particle sizes were about 40 and 50 nm for α-Fe2O3 and Ag-doped α-Fe2O3 NPs, respectively. In addition, the particles were observed to be nearly spherical. According to the hysteresis loop, the saturation magnetization (Ms) of α-Fe2O3 and Ag-dop-α-Fe2O3 NPs was expressed to be 1.5 and 0.16 emu/g, respectively. The high potential of α-Fe2O3 and Ag-dop-α-Fe2O3 NPs in preforming cytotoxic activities against breast cancer (MCF-7) cells approved by outcomes of MTT. So, the synthesized nanoparticles can be proposed as potential choice for being exerted in advanced medical approaches.

The authors report no conflicts of interest in this work.

  1. Saeedi, M., et al., Applications of nanotechnology in drug delivery to the central nervous system. Biomedicine & pharmacotherapy, 2019. 111: p. 666-675.
  2. Nakhaei, P., et al., Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol. Frontiers in Bioengineering and Biotechnology, 2021. 9.
  3. Fathi Karkan, S., et al., Magnetic nanoparticles in cancer diagnosis and treatment: a review. Artificial cells, nanomedicine, and biotechnology, 2017. 45(1): p. 1-5.
  4. Miri, A., et al., Iron oxide nanoparticles: biosynthesis, magnetic behavior, cytotoxic effect. ChemistryOpen, 2021. 10(3): p. 327-333.
  5. Mohamed, N.A., et al., Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases. International Journal of Molecular Sciences, 2022. 23(3): p. 1404.
  6. Sanna, V., N. Pala, and M. Sechi, Targeted therapy using nanotechnology: focus on cancer. International journal of nanomedicine, 2014. 9: p. 467.
  7. Miri, A. and M. Sarani, Silver nanoparticles: cytotoxic and apoptotic activity on HT-29 and A549 cell lines. J. New Develop. Chem., 2018. 4: p. 10.
  8. Nasirmoghadas, P., et al., Nanoparticles in cancer immunotherapies: An innovative strategy. Biotechnology progress, 2021. 37(2): p. e3070.
  9. Wilkinson, L. and T. Gathani, Understanding breast cancer as a global health concern. The British Journal of Radiology, 2022. 95(1130): p. 20211033.
  10. Ghoncheh, M., et al., Epidemiology, incidence and mortality of breast cancer in Asia. Asian Pacific journal of cancer prevention, 2016. 17(sup3): p. 47-52.
  11. Shakil, M.S., M. Hasan, and S.R. Sarker, Iron oxide nanoparticles for breast cancer theranostics. Current drug metabolism, 2019. 20(6): p. 446-456.
  12. Khatami, M., et al., Green Synthesis of Amorphous Iron Oxide Nanoparticles and their Antimicrobial Activity against Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli. Iran J Biotechnol, 2019. 10: p. 33-39.
  13. Sarani, M., et al., Study of in vitro cytotoxic performance of biosynthesized α-Bi2O3 NPs, Mn-doped and Zn-doped Bi2O3 NPs against MCF-7 and HUVEC cell lines. Journal of Materials Research and Technology, 2022. 19: p. 140-150.
  14. Kouhbanani, M.A.J., et al., The inhibitory role of synthesized Nickel oxide nanoparticles against Hep-G2, MCF-7, and HT-29 cell lines: the inhibitory role of NiO NPs against Hep-G2, MCF-7, and HT-29 cell lines. Green Chemistry Letters and Reviews, 2021. 14(3): p. 444-454.
  15. Beheshtkhoo, N., et al., Green synthesis of iron oxide nanoparticles by aqueous leaf extract of Daphne mezereum as a novel dye removing material. Applied Physics A, 2018. 124(5): p. 1-7.
  16. Mosleh-Shirazi, S., et al., Biosynthesis, simulation, and characterization of Ag/AgFeO2 core-shell nanocomposites for antimicrobial applications. Applied Physics A, 2021. 127(11): p. 1-8.
  17. Kouhbanani, M.A.J., et al., One-step green synthesis and characterization of iron oxide nanoparticles using aqueous leaf extract of Teucrium polium and their catalytic application in dye degradation. Advances in Natural Sciences: Nanoscience and Nanotechnology, 2019. 10(1): p. 015007.
  18. Behzad, F., et al., An overview of the plant-mediated green synthesis of noble metal nanoparticles for antibacterial applications. Journal of Industrial and Engineering Chemistry, 2021. 94: p. 92-104.
  19. Veisi, H. and F. Ghorbani, Iron oxide nanoparticles coated with green tea extract as a novel magnetite reductant and stabilizer sorbent for silver ions: Synthetic application of Fe3O4@ green tea/Ag nanoparticles as magnetically separable and reusable nanocatalyst for reduction of 4‐ Applied Organometallic Chemistry, 2017. 31(10): p. e3711.
  20. Kaur, K. and A.K. Sidhu, Green synthesis: An eco-friendly route for the synthesis of iron oxide nanoparticles. Frontiers in Nanotechnology, 2021. 3: p. 47.
  21. Mai, T.T., et al., Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer letters, 2012. 321(2): p. 144-153.
  22. Manke, A., L. Wang, and Y. Rojanasakul, Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed research international, 2013. 2013.
  23. Ankamwar, B., et al., Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology, 2010. 21(7): p. 075102.
  24. Wang, L.-S., M.-C. Chuang, and J.-a.A. Ho, Nanotheranostics-a review of recent publications. International journal of nanomedicine, 2012. 7: p. 4679.